PortfoliosLab logoPortfoliosLab logo
Canton Strategic Holdings, Inc. (CNTN)
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Company Info

Highlights

Market Cap
$104.80M
Enterprise Value
$87.77M
EPS (TTM)
-$2.62
EBITDA (TTM)
-$20.11M
Year Range
$0.95 - $9.08
ROA (TTM)
-6.92%
ROE (TTM)
-9.03%

Share Price Chart


Loading graphics...

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Canton Strategic Holdings, Inc.

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Canton Strategic Holdings, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


Loading graphics...

S&P 500 Index

Returns By Period

Canton Strategic Holdings, Inc. (CNTN) has returned 7.92% so far this year and 140.44% over the past 12 months.


Canton Strategic Holdings, Inc.

1D
6.17%
1M
-35.50%
YTD
7.92%
6M
15.14%
1Y
140.44%
3Y*
-77.75%
5Y*
10Y*

Benchmark (S&P 500 Index)

1D
2.91%
1M
-5.09%
YTD
-4.63%
6M
-2.39%
1Y
16.33%
3Y*
16.69%
5Y*
10.18%
10Y*
12.16%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Monthly Returns

Based on dividend-adjusted daily data since Jan 12, 2022, CNTN's average daily return is -0.03%, while the average monthly return is -0.43%.

Historically, 25% of months were positive and 75% were negative. The best month was Aug 2025 with a return of +377.9%, while the worst month was Nov 2023 at -78.4%. The longest winning streak lasted 3 consecutive months, and the longest losing streak was 8 months.

On a daily basis, CNTN closed higher 43% of trading days. The best single day was Aug 20, 2025 with a return of +206.8%, while the worst single day was Nov 28, 2023 at -72.4%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
202661.39%3.68%-35.50%7.92%
2025-3.45%-27.04%-4.90%27.21%-16.06%33.60%-35.83%377.91%-52.27%3.87%-11.86%16.54%49.26%
2024-13.56%-12.55%11.80%-15.60%-12.87%-25.61%-4.25%-19.53%-8.82%14.92%-27.02%-2.40%-73.41%
2023207.85%-9.17%-27.38%-44.21%-18.59%1.47%-3.84%-32.33%-15.75%-22.30%-78.38%-39.40%-94.78%
202215.52%-53.73%-13.98%-22.50%-29.76%-10.51%46.25%-13.18%-18.16%-31.14%-29.67%-0.64%-88.80%

Benchmark Metrics

Canton Strategic Holdings, Inc. has an annualized alpha of -14.56%, beta of 0.82, and R² of 0.01 versus S&P 500 Index. Calculated based on daily prices since January 13, 2022.

  • This stock participated in 210.50% of S&P 500 Index downside but only -133.16% of its upside — more exposed to losses than it benefited from rallies.
  • R² of 0.01 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

Alpha
-14.56%
Beta
0.82
0.01
Upside Capture
-133.16%
Downside Capture
210.50%

Return for Risk

Risk / Return Rank

CNTN ranks 77 for risk / return — better than 77% of stocks on our site. You're getting solid returns for the risk taken. A good sign, especially for investors who want growth without excessive volatility.


CNTN Risk / Return Rank: 7777
Overall Rank
CNTN Sharpe Ratio Rank: 6161
Sharpe Ratio Rank
CNTN Sortino Ratio Rank: 9494
Sortino Ratio Rank
CNTN Omega Ratio Rank: 9090
Omega Ratio Rank
CNTN Calmar Ratio Rank: 7575
Calmar Ratio Rank
CNTN Martin Ratio Rank: 6666
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics

The table below present risk-adjusted performance metrics for Canton Strategic Holdings, Inc. (CNTN) and compare them to a chosen benchmark (S&P 500 Index).


CNTNBenchmarkDifference

Sharpe ratio

Return per unit of total volatility

0.57

0.90

-0.32

Sortino ratio

Return per unit of downside risk

3.48

1.39

+2.09

Omega ratio

Gain probability vs. loss probability

1.40

1.21

+0.19

Calmar ratio

Return relative to maximum drawdown

1.85

1.40

+0.45

Martin ratio

Return relative to average drawdown

2.91

6.61

-3.70

Explore CNTN risk-adjusted metrics in detail

Dive deeper into individual metrics with historical trends, benchmark comparisons, and performance across different time periods.

Dividends

Dividend History


Canton Strategic Holdings, Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading graphics...

Worst Drawdowns

The table below displays the maximum drawdowns of the Canton Strategic Holdings, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Canton Strategic Holdings, Inc. was 99.93%, occurring on Apr 9, 2025. The portfolio has not yet recovered.

The current Canton Strategic Holdings, Inc. drawdown is 99.79%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-99.93%Feb 3, 2022798Apr 9, 2025
-26.15%Jan 13, 20224Jan 19, 20223Jan 24, 20227
-2.13%Jan 25, 20221Jan 25, 20222Jan 27, 20223
-1.87%Feb 1, 20221Feb 1, 20221Feb 2, 20222

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading graphics...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Canton Strategic Holdings, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how Canton Strategic Holdings, Inc. is priced in the market compared to other companies in the Biotechnology industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PB Ratio

The chart illustrates the Price-to-Book (P/B) ratio for CNTN in comparison with other companies in the Biotechnology industry. Currently, CNTN has a P/B value of 0.3. This P/B ratio is low compared to industry peers. It might indicate the stock is undervalued or that the company’s assets are not expected to generate strong returns.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items